💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

UPDATE 1-ChemChina-led group buys German chemical firm for $1 bln

Published 2016-01-11, 05:17 a/m
© Reuters.  UPDATE 1-ChemChina-led group buys German chemical firm for $1 bln
BARC
-
DBKGn
-
STAN
-
SYENF
-
ONEX
-

* Purchase is biggest Chinese investment in Germany
* Buyers include ChemChina, PE firm AGIC
* ChemChina adds KraussMaffei to Pirelli purchase

(Adds previous Chinese deals in Germany, AGIC comments)
By Elzio Barreto
HONG KONG, Jan 11 (Reuters) - A group of Chinese investors
including China National Chemical Corp (ChemChina) CNNCC.UL
agreed on Monday to buy KraussMaffei Group GmbH KMGER.UL for
925 million euros ($1.01 billion), in the biggest-ever Chinese
investment into Germany.
The group, which also included Guoxin International
Investment Corp and private equity firm AGIC Capital, agreed to
buy the plastics processing machinery maker from Canada's Onex
Corp OCX.TO , AGIC and Onex said in separate statements,
confirming a Reuters report on Jan 7.
The amount surpassed the previous record for Chinese
investment in Germany set in 2012 when construction firm Sany
Heavy Industry Co Ltd 600031.SS bought concrete pump maker
Putzmeister Holding GmbH for $698 million, Thomson Reuters data
showed.
The deal also marked the most recent example of Chinese
firms looking to improve technology, know-how and branding with
overseas acquisitions.
"We see big opportunities in industrial development,
particularly in intelligent manufacturing," said Henry Cai, a
former China dealmaker at Deutsche Bank (DE:DBKGn) and UBS that launched
AGIC Capital in 2015.
For ChemChina, the deal comes after a 7.3 billion euro
purchase last year of tyre manufacturer Pirelli SpA PIRI.UL
and talks to buy Swiss agrichemicals group Syngenta AG
SYNN.VX .
The KraussMaffei transaction is likely to close in the first
half of 2016 subject to regulatory approval, Onex said in a
statement. The Canadian firm bought KraussMaffei from U.S.
investor Madison Capital in 2012 in a 568 million euro deal.

The investment is the first for AGIC, which launched its
initial fund in March and raised $500 million by August with a
target to raise another $500 million in coming months before a
final close, Cai said.
Standard Chartered (L:STAN) advised the buyer group and Barclays (L:BARC)
advised KraussMaffei, said a person familiar with the deal who
declined to be identified as advisers have not been publicly
disclosed.
ChemChina did not immediately respond to an email seeking
comment on the deal. Guoxin could not be reached for comment.

($1 = 0.9159 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.